March 23 2015

Scandinavian Micro Biodevices (SMB) reports its best financial result in 2014 with an increase of 13 % in profit and strengthens management by employing Henrik Kristian Moltke as CFO.

SMB continues to progress positively with an increase of 13 % in profit, on top of a 2013 result which was record high, to a EBT of 4.6 million DKK in 2014. The positive development is fuelled by market expansion in the "point of care" (POC) veterinarian market where the number of cartridges sold compared to last year increased with no less than 20%, combined with a strong focus on optimizing and automation of the production. 2014 was also a continuation of the company’s strategy of investing in new products and platforms within the company’s technology base. The main focus is to develop new game changing products which can be used within both the veterinary and human "point of care" (POC) market. 

 

SMB has at the start of 2015 employed Henrik Kristian Moltke as CFO. Henrik has a long and excellent career within health care and finance. Henrik will work on the continued professionalization of the SMB organization and execute on the strategy going forward. 

 

 

Ole Kring, CEO states “We are very satisfied with the development in 2014 because it is the best financial result ever and at the same time we have progressed our technology base and product development significantly which places us in a very strong position for continued growth in the coming years” and continues “I am also very happy to welcome Henrik on board as CFO. Henrik brings a huge experience in finance, strategy and business development to our company and will contribute to our success going forward”.